Clinical Trial: ECOG-ACRIN EA5221

ECOG-ACRIN EA5221

Status: Open

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study

Eligible for screening study DCP 001